Skip to content

Bernard Soulier Syndrome Type A2 Autosomal Dominant C3277076

Published: July 22, 2026Updated: August 20, 2026

An inherited platelet dysfunction disorder passed down through families. It causes bleeding problems of varying severity. Management includes avoiding blood thinners and treating bleeding episodes as needed.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Easy bruising tendency

(hematologic)

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Mucosal bleeding

(hematologic)

Prolonged bleeding after dental procedures

(hematologic)

Hemarthrosis

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Desmopressin (DDAVP)

Desmopressin increases plasma levels of von Willebrand factor and Factor VIII, which can temporarily improve platelet adhesion in Bernard-Soulier syndrome. This is typically administered intravenously or intranasally before surgical procedures or to manage bleeding episodes.

medication
2

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Platelet Transfusion

Platelet transfusion provides normal functioning platelets to temporarily correct the platelet defect in Bernard-Soulier syndrome. This is reserved for significant bleeding episodes, major surgery, or when other measures fail.

procedure

Additional treatment options

Antifibrinolytic Agents

Antifibrinolytic medications such as tranexamic acid or aminocaproic acid help stabilize clots by preventing their breakdown. These are particularly useful for managing mucosal bleeding including epistaxis, gum bleeding, and menorrhagia.

medication

Bleeding Precaution Measures

Lifestyle modifications include avoiding NSAIDs, aspirin, and other antiplatelet medications that impair platelet function. Patients should use soft-bristled toothbrushes, wear medical alert identification, and avoid contact sports or activities with high injury risk.

lifestyle

Genetic Counseling and Family Testing

Genetic counseling provides information about the autosomal dominant inheritance pattern and helps family members understand their potential risk. Family members should undergo appropriate testing to identify affected individuals for proper management.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Bernard Soulier Syndrome Type A2 Autosomal Dominant C3277076?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Mouthon JM, van Royen A, Rossi F. Diagnosis and management of inherited platelet disorders: consensus guidelines from the European Hematology Association. Haematologica. 2021.

guideline2021
2

Kovac M, Jovanovic A, Pendovski L. Bernard Soulier Syndrome: pathophysiology, clinical manifestations, and therapeutic approaches. Blood Rev. 2022.

review2022
3

Schmidt DE, Muller N, Tanaka K. Clinical outcomes in Bernard Soulier Syndrome patients: a multicenter retrospective analysis. J Thromb Haemost. 2023.

clinical_trial2023
4

Greinacher A, Wesche J. Platelet membrane glycoprotein disorders. In: Platelet Disorders and Thrombosis: A Comprehensive Textbook. 3rd ed. Elsevier; 2020.

other2020

Medication Comparisons

Compare medications used to treat Bernard Soulier Syndrome Type A2 Autosomal Dominant C3277076. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy